Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iRhythm Holdings (IRTC) Asset Writedowns and Impairment (2018 - 2025)

Historic Asset Writedowns and Impairment for iRhythm Holdings (IRTC) over the last 8 years, with Q2 2025 value amounting to $2.5 million.

  • iRhythm Holdings' Asset Writedowns and Impairment changed N/A to $2.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 7342.65%. This contributed to the annual value of $641000.0 for FY2024, which is 9422.52% down from last year.
  • Latest data reveals that iRhythm Holdings reported Asset Writedowns and Impairment of $2.5 million as of Q2 2025.
  • Over the past 5 years, iRhythm Holdings' Asset Writedowns and Impairment peaked at $23.2 million during Q1 2022, and registered a low of -$5.9 million during Q4 2021.
  • For the 5-year period, iRhythm Holdings' Asset Writedowns and Impairment averaged around $4.7 million, with its median value being $2.3 million (2021).
  • As far as peak fluctuations go, iRhythm Holdings' Asset Writedowns and Impairment tumbled by 5545.79% in 2021, and later skyrocketed by 64959.61% in 2022.
  • iRhythm Holdings' Asset Writedowns and Impairment (Quarter) stood at -$5.9 million in 2021, then surged by 494.29% to $23.2 million in 2022, then plummeted by 52.16% to $11.1 million in 2023, then crashed by 94.23% to $641000.0 in 2024, then surged by 286.74% to $2.5 million in 2025.
  • Its Asset Writedowns and Impairment was $2.5 million in Q2 2025, compared to $641000.0 in Q3 2024 and $11.1 million in Q4 2023.